Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Active not recruiting × Osteosarcoma × Clear all

Phase

Phase 2 19 Phase 1 8 Phase 1/2 3 Phase NA 2 Phase 3 1

Status

Completed 5 Terminated 2 Recruiting 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 94 Carcinoma, Non-Small-Cell Lung 82 Prostatic Neoplasms 48 Multiple Myeloma 41 Neoplasms 31 Neoplasm Metastasis 29 Ovarian Neoplasms 23 Melanoma 21 Urinary Bladder Neoplasms 18 Recurrence 18 Parkinson Disease 4, Autosomal Dominant Lewy Body 18 Leukemia, Lymphocytic, Chronic, B-Cell 18 Carcinoma, Renal Cell 18 Lung Neoplasms 16 Leukemia, Myeloid, Acute 16 Carcinoma, Hepatocellular 16 Colorectal Neoplasms 15 Triple Negative Breast Neoplasms 14 Stomach Neoplasms 14 Nasopharyngeal Carcinoma 14 Lymphoma, Non-Hodgkin 13 Lymphoma, Large B-Cell, Diffuse 13 Colonic Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma 11 Carcinoma 11 Papillomavirus Infections 10 Fallopian Tube Neoplasms 10 Endometrial Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9

Interventions

Zoledronic Acid 1 Methotrexate 1 Ifosfamide 1 Etoposide 1 Doxorubicin 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00470223 2025-06-08

OS2006

UNICANCER

Phase 3 Active not recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡